CLINICAL_TRIALS
trial_result
· 2017-12-11
Clinical Trial Update: FUTURE 3 Study Extension [Phase 3]
Summary
Actelion reported the FUTURE 3 study extension for pulmonary arterial hypertension has completed and results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Actelion | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2017-12-11